22944116

Zhou JQ

2012

Polycystic ovary syndrome in patients with epilepsy: a study in 102 Chinese women.

22945299

Tao T

2012

Expression of the CD11c gene in subcutaneous adipose tissue is associated with cytokine level and insulin resistance in women with polycystic ovary syndrome.

22948218

Wang Q

2012

Chemerin, a novel regulator of follicular steroidogenesis and its potential involvement in polycystic ovarian syndrome.

22948504

Kogure GS

2012

[Analysis of muscle strength and body composition of women with polycystic ovary syndrome].

22948505

Lombardi LA

2012

[Morphology of the interstitial cells of rat polycystic ovaries: an experimental study].

22948766

Robin G

2012

Polycystic Ovary-Like Abnormalities (PCO-L) in women with functional hypothalamic amenorrhea.

22951108

Duncan WC

2013

Targeting angiogenesis in the pathological ovary.

22951595

Hwang JY

2012

Genome-wide association study identifies GYS2 as a novel genetic factor for polycystic ovary syndrome through obesity-related condition.

22951915

Haouzi D

2012

Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome.

22953622

Jakubowicz D

2012

The link between polycystic ovarian syndrome and type 2 diabetes: preventive and therapeutic approach in Israel.

22954591

Sandoval-Guzm?n T

2012

Neuroendocrine control of female reproductive function by the activin receptor ALK7.

22956412

Misso ML

2013

Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis.

22956770

Guzman L

2013

Human antral follicles <6 mm: a comparison between in vivo maturation and in vitro maturation in non-hCG primed cycles using cumulus cell gene expression.

22959299

Erko?o?lu M

2013

The effect of oral contraceptives on current wheezing in young women.

22959450

Ortega I

2012

Effects of resveratrol on growth and?function of rat ovarian granulosa cells.

22959458

Galazis N

2012

Proteomic biomarkers for ovarian cancer risk in women with polycystic ovary syndrome: a systematic review and biomarker database integration.

22959762

Okoroh EM

2012

Is polycystic ovary syndrome another risk factor for venous thromboembolism? United States, 2003-2008.

22960769

Abuzeid MI

2012

Early initiation of gonadotropin-releasing hormone antagonist in polycystic ovarian syndrome patients undergoing assisted reproduction: randomized controlled trial ISRCTN69937179.

22963806

Moro F

2012

CD4(+)CD28(null) T lymphocyte frequency, a new marker of cardiovascular risk: relationship with polycystic ovary syndrome phenotypes.

22964806

Du Q

2012

Comparative efficacy of thiazolidinediones and metformin for polycystic ovary syndrome.

22966246

Franasiak J

2012

Longitudinal anti-m?llerian hormone in women with polycystic ovary syndrome: an acupuncture randomized clinical trial.

22970350

Jakubowski KP

2012

Parents' Readiness to Change Affects BMI Reduction Outcomes in Adolescents with Polycystic Ovary Syndrome.

22970510

Gebel E

2012

A syndrome of their own: PCOS and its links to diabetes in women.

22971456

Alserri A

2012

Serum albumin levels in women with ovarian hyperstimulation syndrome with or without polycystic ovaries.

22972055

Hickey M

2012

Progestogens with or without oestrogen for irregular uterine bleeding associated with anovulation.

22975477

Manikkam M

2012

Pesticide and insect repellent mixture (permethrin and DEET) induces epigenetic transgenerational inheritance of disease and sperm epimutations.

22977634

K???? N

2011

Relationship of ovarian volume with mean platelet volume and lipid profile in patients with polycystic ovary syndrome.

22978715

Toth PP

2012

The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus.

22982716

S?ra L

2012

Arteriolar biomechanics in a rat polycystic ovary syndrome model - effects of parallel vitamin D3 treatment.

22985575

Luo X

2012

[Association of fat distribution with metabolic syndrome in patients with polycystic ovary syndrome].

22985947

Trottier A

2012

Adipose tissue insulin resistance in peripubertal girls with first-degree family history of polycystic ovary syndrome.

22988703

Savill P

2012

Identifying patients at risk of type 2 diabetes.

22989359

van Tilborg TC

2012

The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial.

22993908

Katulski K

2012

[The controversies in the diagnosis of polycystic ovary syndrome].

22994049

Wu CC

2012

[Effects of oral contraceptive pretreatment on controlled ovarian hyperstimulation and outcomes of IVF-ET].

22994662

Kamangar F

2012

Acne in the adult female patient: a practical approach.

22995747

Moran LJ

2012

Weight loss and vascular inflammatory markers in overweight women with and without polycystic ovary syndrome.

22997798

Liang FX

2012

[Discussion on clinical research thinking of insulin resistance and its related di-seases treated with acupuncture and moxibustion].

22998438

Cakir GA

2013

Isotretinoin treatment in nodulocystic acne with and without polycystic ovary syndrome: efficacy and determinants of relapse.

22999261

Kashani L

2013

Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression.

22999793

Vigerust NF

2012

Free carnitine and acylcarnitines in?obese patients with polycystic ovary syndrome and effects of?pioglitazone treatment.

23001778

Nahuis MJ

2012

Long-term follow-up of laparoscopic electrocautery of the ovaries versus ovulation induction with recombinant FSH in clomiphene citrate-resistant women with polycystic ovary syndrome: an economic evaluation.

23001781

Mart?nez-Garc?a M?

2012

Common variants in the sex hormone-binding globulin gene (SHBG) and polycystic ovary syndrome (PCOS) in Mediterranean women.

23006146

Vanky E

2012

On the potential of metformin to prevent preterm delivery in women with polycystic ovary syndrome - an epi-analysis.

23008094

Liu Y

2013

Uncoupling protein 2 expression affects androgen synthesis in polycystic ovary syndrome.

23012389

Wang ET

2012

Polycystic ovary syndrome is associated with higher left ventricular mass index: the CARDIA women's study.

23017309

Mohammadi E

2012

Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome.

23017717

Dos Santos E

2012

Adiponectin and reproduction.

23017719

Palin MF

2012

Adiponectin and the control of female reproductive functions.

23018469

de Oliveira Baraldi C

2012

Effect of type 2 diabetes mellitus on the pharmacokinetics of metformin in obese pregnant women.

23022527

Park JH

2012

Polycystic ovary syndrome (PCOS)-like phenotypes in the d-galactose-induced aging mouse model.

23022879

K?rolyi Z

2012

[The pathomechanism of polycystic ovary syndrome in the light of recent research findings].

23023351

Dasgupta S

2012

Does follistatin gene have any direct role in the manifestation of polycystic ovary syndrome in Indian women?

23025880

Di Domenico K

2013

Cardiac autonomic modulation in polycystic ovary syndrome: does the phenotype matter?

23028012

Galobardes B

2012

The association between irregular menstruations and acne with asthma and atopy phenotypes.

23035769

Sella T

2013

Screening for gestational diabetes in the 21st century: a population-based cohort study in Israel.

23036804

?ahin N

2013

The levels of hepatocyte growth factor in serum and follicular fluid and the expression of c-Met in granulosa cells in patients with polycystic ovary syndrome.

23046078

Mani H

2013

Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study.

23046530

Tsai YH

2013

Dietary intake, glucose metabolism and sex hormones in women with polycystic ovary syndrome (PCOS) compared with women with non-PCOS-related infertility.

23056290

Zhang B

2012

Association study of gene LPP in women with polycystic ovary syndrome.

23058684

Masszi G

2013

Altered insulin-induced relaxation of aortic rings in a dihydrotestosterone-induced rodent model of polycystic ovary syndrome.

23063820

Walls M

2012

IVF versus ICSI for the fertilization of in-vitro matured human oocytes.

23065162

Lee TT

2012

Polycystic ovarian syndrome: role of imaging in diagnosis.

23065822

Diamanti-Kandarakis E

2012

Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

23071212

Carlsen SM

2012

Metformin's effect on first-year weight gain: a follow-up study.

23071860

Tao T

2012

Early impaired ?-cell function in chinese women with polycystic ovary syndrome.

23072215

Zhu JP

2013

Increased mean glucose levels in patients with polycystic ovary syndrome and hyperandrogenemia as determined by continuous glucose monitoring.

23072616

Awwad J

2012

Fever in women may interfere with follicular development during controlled ovarian stimulation.

23072795

Upadhyay RD

2013

Proteomics in reproductive biology: beacon for unraveling the molecular complexities.

23073543

Laggari V

2012

[Uterovaginal agenesis and polycystic ovary syndrome: psychological disturbance in adolescence].

23073722

Sarkar C

2013

Elucidation of regulatory mechanisms revealed by human promoter sequence analysis of genes co-expressed in forskolin-treated theca cells in PCOS.

23074008

Legro RS

2012

Obesity and PCOS: implications for diagnosis and treatment.

23074009

Kumbak B

2012

Female obesity and assisted reproductive technologies.

23076041

Nicandri KF

2012

Diagnosis and treatment of polycystic ovarian syndrome in adolescents.

23076844

Markopoulos MC

2013

Study of carbohydrate metabolism indices and adipocytokine profile and their relationship with androgens in polycystic ovary syndrome after menopause.

23076922

Sinawat S

2012

Long versus short course treatment with metformin and clomiphene citrate for ovulation induction in women with PCOS.

23079471

Kosova G

2013

Genetics of the polycystic ovary syndrome.

23080278

Pedroso DC

2012

[Frequency and risk factors for metabolic syndrome in adolescents and adults women with polycystic ovary syndrome].

23081959

Leonhardt H

2012

Uterine morphology and peristalsis in women with polycystic ovary syndrome.

23084689

Dunne C

2012

Malignant ovarian Sertoli-Leydig cell tumor localized with selective ovarian vein sampling.

23084976

Padmanabhan V

2013

Sheep models of polycystic ovary syndrome phenotype.

23084977

Balen AH

2013

Ovulation induction in the management of anovulatory polycystic ovary syndrome.

23084978

Barber TM

2013

Adipocyte biology in polycystic ovary syndrome.

23086704

Casano S

2012

MILD ovarian stimulation with GnRH-antagonist vs. long protocol with low dose FSH for non-PCO high responders undergoing IVF: a prospective, randomized study including thawing cycles.

23089114

Heber MF

2012

[The role of prenatal hyperandrogenism on lipid metabolism during adult life in a rat model].

23089571

Geier LM

2012

Factors contributing to initial weight loss among adolescents with polycystic ovary syndrome.

23089573

Li L

2012

Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents.

23093701

Galazis N

2013

Proteomic biomarkers of type 2 diabetes mellitus risk in women with polycystic ovary syndrome.

23094634

Pavone M

2012

Continuous positive pressure non-invasive ventilation for the management of obstructive sleep apnoea in a 15-year-old girl with polycystic ovary syndrome.

23097354

Gianaroli L

2012

Best practices of ASRM and ESHRE: a journey through reproductive medicine.

23098676

McNeilly AS

2013

Rodent models of polycystic ovary syndrome.

23102586

Yasmin E

2013

The association of body mass index and biochemical hyperandrogenaemia in women with and without polycystic ovary syndrome.

23103018

Benetti-Pinto CL

2013

Subclinical hypothyroidism in young women with polycystic ovary syndrome: an analysis of clinical, hormonal, and metabolic parameters.

23105767

Saha S

2008

Correlation between serum lipid profile and carotid intima-media thickness in Polycystic Ovarian Syndrome.

23108198

Usadi RS

2012

Reproductive impact of polycystic ovary syndrome.

23108199

Huang G

2012

Clinical update on screening, diagnosis and management of metabolic disorders and cardiovascular risk factors associated with polycystic ovary syndrome.

23108387

Zhang HY

2013

Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study.

23109645

Panidis D

2013

Association between menstrual cycle irregularities and endocrine and metabolic characteristics of the polycystic ovary syndrome.

23114091

Lim SS

2013

The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis.

23114640

Tang T

2013

Use of metformin for women with polycystic ovary syndrome.